Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases

Summary

Insilico Medicine and China Medical System Holdings Limited announced additional collaborations in CNS disease R&D using AI-powered approaches. The expansion deepens their existing partnership in artificial intelligence-driven drug discovery and development.